Pacific Biosciences of California, Inc. revenue by segment PACB

Pacific Biosciences of California, Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Consumables at $81.9 million, 51% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
161
160
154
201
128
131
79
91
79
93
91
Consumables
84
+6.6%
share 52.3%
82
+16.4%
share 51.2%
70
+11.0%
share 45.7%
63
+5.7%
share 31.6%
60
+14.9%
share 46.7%
52
+67.6%
share 40.0%
31
-4.5%
share 39.5%
33
share 35.9%
—
—
—
Instrument
53
+2.5%
share 32.9%
54
-18.2%
share 33.6%
66
-45.4%
share 42.7%
120
+147.2%
share 60.1%
49
-20.6%
share 38.0%
61
+78.9%
share 47.0%
34
-24.0%
share 43.5%
45
share 49.6%
—
—
—
Service And Other
24
+1.1%
share 14.8%
24
+35.7%
share 15.2%
18
+7.3%
share 11.6%
17
-15.1%
share 8.3%
20
+15.3%
share 15.3%
17
+26.3%
share 13.0%
13
+2.4%
share 17.1%
13
share 14.5%
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
PACB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Accelerated filer
SEC CIK
1299130
Former names
PACIFIC BIOSCIENCES OF CALIFORNIA INC (until Feb 5, 2013); NANOFLUIDICS INC (until Jul 28, 2004)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.